|
LOC100133991 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.731820E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.664560E-03 |
| Normal-vs-Stage2 |
9.868200E-01 |
| Normal-vs-Stage3 |
2.968200E-01 |
| Normal-vs-Stage4 |
5.558600E-01 |
| Stage1-vs-Stage2 |
2.917800E-02 |
| Stage1-vs-Stage3 |
5.680100E-02 |
| Stage1-vs-Stage4 |
1.244610E-01 |
| Stage2-vs-Stage3 |
4.101800E-01 |
| Stage2-vs-Stage4 |
6.113800E-01 |
| Stage3-vs-Stage4 |
8.758400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.321900E-03 |
| Normal-vs-AfricanAmerican |
1.765230E-01 |
| Normal-vs-Asian |
3.308500E-02 |
| Caucasian-vs-AfricanAmerican |
9.553000E-01 |
| Caucasian-vs-Asian |
4.935200E-01 |
| AfricanAmerican-vs-Asian |
6.866400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.978200E-01 |
| Normal-vs-Female |
4.822200E-03 |
| Male-vs-Female |
2.001900E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.059170E-03 |
| Normal-vs-Age(41-60Yrs) |
2.581800E-02 |
| Normal-vs-Age(61-80Yrs) |
7.483800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.851200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.079000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.795500E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.774000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.601770E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.288400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.666000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.356800E-03 |
| Classical-VS-Follicular |
1.199460E-04 |
| Classical-VS-Other |
3.546200E-01 |
| Classical-VS-Normal |
3.773100E-04 |
| Tall-VS-Follicular |
4.272200E-01 |
| Tall-VS-Other |
9.861400E-01 |
| Tall-VS-Normal |
6.762400E-01 |
| Follicular-VS-Other |
7.360600E-01 |
| Follicular-VS-Normal |
6.668600E-01 |
| Other-VS-Normal |
8.808600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.490970E-01 |
| Normal-vs-N1 |
4.330100E-02 |
| N0-vs-N1 |
2.086000E-01 |
|
|
